APC13_HUMAN - dbPTM
APC13_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID APC13_HUMAN
UniProt AC Q9BS18
Protein Name Anaphase-promoting complex subunit 13
Gene Name ANAPC13
Organism Homo sapiens (Human).
Sequence Length 74
Subcellular Localization Nucleus .
Protein Description Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains..
Protein Sequence MDSEVQRDGRILDLIDDAWREDKLPYEDVAIPLNELPEPEQDNGGTTESVKEQEMKWTDLALQYLHENVPPIGN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
26PhosphorylationWREDKLPYEDVAIPL
HHCCCCCHHHCEEEH
34.8927642862

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of APC13_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of APC13_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of APC13_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
APC4_HUMANANAPC4physical
22939629
CDC27_HUMANCDC27physical
22939629
CDC16_HUMANCDC16physical
22939629
APC5_HUMANANAPC5physical
22939629
CDC23_HUMANCDC23physical
22939629
APC7_HUMANANAPC7physical
22939629
CDC26_HUMANCDC26physical
22939629
TAF4_HUMANTAF4physical
26344197
APC4_HUMANANAPC4physical
28514442
CDC16_HUMANCDC16physical
28514442
ANC2_HUMANANAPC2physical
28514442
CDC26_HUMANCDC26physical
28514442
CDC27_HUMANCDC27physical
28514442
CDC23_HUMANCDC23physical
28514442
APC5_HUMANANAPC5physical
28514442
APC1_HUMANANAPC1physical
28514442
APC16_HUMANANAPC16physical
28514442
APC7_HUMANANAPC7physical
28514442
FZR1_HUMANFZR1physical
28514442
FBX5_HUMANFBXO5physical
28514442
APC10_HUMANANAPC10physical
28514442

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of APC13_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP